Johnson & Johnson’s MedTech Momentum Expected to Rebound in 2025 Despite Current Hurdles, Analyst Says
Welcome to our blog! Johnson & Johnson Reports Fourth Quarter Earnings On Wednesday, Johnson & Johnson (JNJ) released its fourth-quarter financial results. The company reported an adjusted earnings per share (EPS) of $2.04, which was a 10.9% decrease compared to the previous year. However, this still surpassed analysts’ expectations of $2.01 per share. Analysis of…